Competing Interest
This study was supported by Grants-in-Aid for Scientific Research
(KAKENHI) from the Ministry of Education, Culture, Sports, Science and
Technology of Japan (subject ID: 19K08726 to Kandai Nozu, 17H04189 to
Kazumoto Iijima and), by the Japan Agency for Medical Research and
Development (AMED) (Grant Number JP19ek0109231h0003 to Kandai Nozu and
Kazumoto Iijima).
Kandai Nozu has received consulting fees from Kyowa Kirin Co., Ltd.; and
lecture fees from Kyowa Kirin Co., Ltd., Novartis Pharmaceuticals
Corporation, and Chugai Pharmaceutical Co., Ltd.
Kazumoto Iijima has received grant support from Daiichi Sankyo Co.,
Ltd.; consulting fees from Kyowa Kirin Co., Ltd., and Boehringer
Ingelheim; and lecture fees from Kyowa Kirin Co., Ltd., Chugai
Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company, Integrated
Development Associates, and Novartis Pharmaceuticals Corporation.
The other authors declare that no conflict interests exsist.